HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sun Chem's in situ color lakes alternative manufacturing process complies with FDA.

This article was originally published in The Rose Sheet

Executive Summary

SUN CHEM's MODIFIED IN SITU COLOR ADDITIVE LAKES MANUFACTURING METHOD COMPLIANT with FDA specifications, the agency determined after reviewing the company's data on the alternative lakes development method. FDA asked Staten Island, N.Y.-based Sun Chemical Corp. to investigate whether it is "technically feasible" to replace the current in situ process with a substitute procedure to develop color additive lakes for D&C Red No. 34. Under the alternative process, the dried sodium salt form of D&C Red 34 is used to provide manufacturers with a water-soluble certifiable color additive from which to prepare a calcium lake, FDA said. The agency analyzed Sun Chemical's data and confirmed the results.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005516

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel